Drug-associated pine necrosis
Prosthetic pressure provoked drug-associated pine necrosis in the lower jaw >MKG Heidelberg
Bedogni, A., S. Fedele, et al. (2014). "Staging of osteonecrosis of the jaw requires computed tomography for accurate definition of the extent of bony disease." Br J Oral Maxillofac Surg.
Bedogni, A., G. Saia, et al. (2011). "Long-term outcomes of surgical resection of the jaws in cancer patients with bisphosphonate-related osteonecrosis." Oral Oncol 47 (5): 420-424.
de-Freitas, N.R., L.B. Lima, et al. (2016). "Bisphosphonates treatment and dental implants: A systematic review." Medicina Oral Patología Oral y Cirugia Bucal: 0.
Dearnaley, D.P., M.D. Mason, et al. (2009). "Adjuvant therapy with oral sodium clodronate in locally advanced and metastatic prostate cancer: long-term overall survival results from the MRC PR04 and PR05 randomized controlled trials." Lancet Oncol 10 (9): 872-876.
El-Rabbany, M., A. Sgro, et al. (2017). "Effectiveness of treatments for medication-related osteonecrosis of the jaw: A systematic review and meta-analysis." J Am Dent Assoc. 148 (8): 584-594 e582.
Fedele, S., G. Bedogni, et al. (2015). "Up to a quarter of patients with osteonecrosis of the jaw associated with antiresorptive agents remain undiagnosed." Br J Oral Maxillofac Surg 53 (1): 13-17.
Fliefel, R., M. Troltzsch, et al. (2015). "Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review." Int J Oral Maxillofac Surg 44 (5): 568-585.
Giovannacci, I., M. Meleti, et al. (2016). "Medication-Related Osteonecrosis of the Jaw Around Dental Implants: Implant Surgery-Triggered or Implant Presence-Triggered Osteonecrosis?" The Journal of Craniofacial Surgery 27 (3): 697-701.
Goodday, R.H. (2015). "Preventive Strategies for Patients at Risk of Medication-related Osteonecrosis of the Jaw." Oral Maxillofac Surg Clin North On 27 (4): 527-536.
Grötz, K., J.-U. Piesold, et al. (2012). Bisphosphonate-associated pine necrosis (BP-ONJ) and other drug-associated pine necrosis. AWMF online (www.awmf.org).
Grötz, K. and B. Al-Nawas (2016). "Antiresorptive-associated pine necrosis." Maxillofacial Surgeon (9): 207-217.
Guggenberger, R., D.R. Fischer, et al. (2013). "Bisphosphonate-induced osteonecrosis of the jaw: a comparison of disease-related MR imaging, [18F] fluoride PET / CT, and conebeam CT imaging." AJNR Am J Neuroradiol 34 (6): 1242-1247.
Hallmer, F., T. Bjornland, et al. (In 2014). "Osteonecrosis of the jaw in patients treated with oral and intravenous bisphosphonates: experience in Sweden." Oral Surg Oral Med Oral Pathol Oral Radiol 118 (2): 202-208.
Hansen, T., M. Kunkel, et al. (2006). "Osteonecrosis of the jaws in patients treated with bisphosphonates – histomorphologic analysis in comparison with infected osteoradionecrosis." J Oral Pathol Med 35 (3): 155-160.
Hasegawa, T., A. Kawakita, et al. (2017). "A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy?" Osteoporos Int.
Hasegawa, Y., M. Kawabe, et al. (2012). "Influence of dentures in the initial occurrence site on the prognosis of bisphosphonate-related osteonecrosis of the jaws: A retrospective study." Oral surgery, oral medicine, oral pathology and oral radiology 114 (3): 318-324.
Hoefert, S. and H. Eufinger (2011). "Relevance of a prolonged preoperative antibiotic regimen in the treatment of bisphosphonate-related osteonecrosis of the jaw." J Oral Maxillofac Surg 69 (2): 362-380.
Hoff, A.O., B.B. Toth, et al. (2008). "Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates." J Bone Miner Res 23 (6): 826-836.
Khan, A.A., A. Morrison, et al. (2015). "Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus." J Bone Miner Res 30 (1): 3-23.
Kyrgidis, A., S. Triaridis, et al. (2012). "Quality of life in breast cancer patients with bisphosphonate-related osteonecrosis of the jaws and patients with head and neck cancer: a comparative study using the EORTC QLQ-C30 and QLQ-HN35 questionnaires." Anticancer Res 32 (8): 3527-3534.
Lo, J.C., F.S. O’Ryan, et al. (2010). "Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure." J Oral Maxillofac Surg 68 (2): 243-253.
Marx, R.E. (2003). "Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic." J Oral Maxillofac Surg 61 (9): 1115-1117.
Matsumoto, A., M. Sasaki, et al. (2017). "Osteonecrosis of the jaw in patients under denosumab." Clin Oral Investig 21 (1): 127-134.
Montefusco, V., et al., Antibiotic prophylaxis before dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple myeloma-treated with bisphosphonates. Leuk Lymphoma, 2008. 49 (11): p. 2156-62.
Mozzati, M., V. Arata, et al. (2013). "Tooth extraction in osteoporotic patients taking oral bisphosphonates." Osteoporos Int 24 (5): 1707-1712.
Nicolatou-Galitis, O., E. Papadopoulou, et al. (2011). "Osteonecrosis of the jaw in oncology patients treated with bisphosphonates: prospective experience of a dental oncology referral center." Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112 (2): 195-202.
Nicolatou-Galitis, O., E. Razis, et al. (2015). "Periodontal disease preceding osteonecrosis of the jaw (ONJ) in cancer patients receiving antiresorptive alone or combined with targeted therapies: report of 5 cases and literature review." Oral surgery, oral medicine, oral pathology and oral radiology 120 (6): 699-706.
Niibe, K., T. Ouchi, et al. (2015). "Osteonecrosis of the jaw in patients with dental prosthesis being treated with bisphosphonates or denosumab." Journal of prosthodontic research 59 (1): 3-5.
Otto, S., S. Hafner, et al. (2009). "The role of inferior alveolar nerve involvement in bisphosphonate-related osteonecrosis of the jaw." J Oral Maxillofac Surg 67 (3): 589-592.
Otto, S., C. Pautke, et al. (2010). "Osteonecrosis of the jaw: effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism." J Oral Maxillofac Surg 68 (11): 2837-2845.
Otto, S., C. Pautke, et al. (2018). "Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management of patients with cancer and bone metastases." Cancer Treat Rev 69: 177-187.
Otto, S., O. Ristow, et al. (2016). "Fluorescence-guided surgery for the treatment of osteonecrosis of the jaw: A prospective cohort study." J Craniomaxillofac Surg 44 (8): 1073-1080.
Otto, S., M. Troltzsch, et al. (2015). "Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: A trigger for BRONJ development?" J Craniomaxillofac Surg 43 (6): 847-854.
Panya, S., R. Fliefel, et al. (2017). "Role of microbiological culture and polymerase chain reaction (PCR) of actinomyces in osteonecrosis of the jaw (MRONJ)." J Craniomaxillofac Surg 45 (3): 357-363.
Papapoulos, S., K. Lippuner, et al. (2015). "The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study." Osteoporos Int 26 (12): 2773-2783.
Poxleitner, P., M. Engelhardt, et al. (2017). "The Prevention of Medication-related Osteonecrosis of the Jaw." Dtsch Arztebl Int 114 (5): 63-69.
Raje, N., E. Terpos, et al. (2018). "Denosumab versus zoledronic acid in bone disease Treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomized, controlled, phase 3 study." Lancet Oncol 19 (3): 370-381.
Rao, N.J., J.Y. Wang, et al. (2017). "Role of Periapical Diseases in Medication-Related Osteonecrosis of the Jaws." BioMed research international 2017: 1560175.
Ripamonti, C.I., M. Maniezzo, et al. (2009). "Decreased occurrence of osteonecrosis of the jaw following implementation of dental preventive measures in solid tumor patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan." Ann Oncol 20 (1): 137-145.
Ristow, O., C. Gerngroß, et al. (2013). "Bisphosphonates of etiological importance for the pathogenesis of the bisphosphonate-related osteonecrosis is the bone turnover of the jawbone and its possible oversuppression?" Journal of Oral and Maxillofacial Surgery.
Ristow, O., C. Gerngross, et al. (2014). "Does regular zoledronic acid change the bone turnover of the jaw in metastatic prostate cancer: a possible clue to the pathogenesis of bisphosphonate related osteonecrosis of the jaw?" J Cancer Res Clin Oncol 140 (3): 487-493.
Ristow, O., S. Otto, et al. (2017). "Comparison of auto-fluorescence and tetracycline fluorescence for guided bone surgery of osteonecrosis of the jaw: a randomized controlled feasibility study." Int J Oral Maxillofac Surg 46 (2): 157-166.
Ristow, O., S. Otto, et al. (2015). "Treatment perspectives for medication-related osteonecrosis of the jaw (MRONJ)." J Craniomaxillofac Surg 43 (2): 290-293.
Ristow, O., T. Ruckschloss, et al. (2018). "A double center closure techniques after bone surgery of osteonecrosis of the jaw – A single center cohort study." J Craniomaxillofac Surg 46 (5): 815-824.
Rugani, P., G. Luschin, et al. (2014). "Prevalence of bisphosphonate-associated osteonecrosis of the jaw after intravenous zoledronate infusion in patients with early breast cancer." Clin Oral Investig 18 (2): 401-407.
Ruggiero, S.L., T.B. Dodson, et al. (2014). "American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw-2014 Update." J Oral Maxillofac Surg.
Ruggiero, S.L. and N. Kohn (2015). "Disease Stage and Mode of Therapy Are Important Determinants of Treatment Outcomes for Medication-Related Osteonecrosis of the Jaw." J Oral Maxillofac Surg 73 (12 Suppl): S94-S100.
Rupel, K., G. Ottaviani, et al. (2014). "A systematic review of therapeutic approaches in bisphosphonates-related osteonecrosis of the jaw (BRONJ)." Oral Oncol 50 (11): 1049-1057.
Saad, F., J.E. Brown, et al. (2012). "Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis of three blinded active-controlled phase III trials in cancer patients with bone metastases." Ann Oncol 23 (5): 1341-1347.
Saia, G., S. Blandamura, et al. (2010). "Occurrence of bisphosphonate-related osteonecrosis of the jaw after surgical tooth extraction." J Oral Maxillofac Surg 68 (4): 797-804.
Schiodt, M., S. Vadhan-Raj, et al. (2018). "A multicenter case registry study on medication-related osteonecrosis of the jaw in patients with advanced cancer." Support Care Cancer 26 (6): 1905-1915.
Sedghizadeh, P.P., S.K. Kumar, et al. (2008). "Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy." J Oral Maxillofac Surg 66 (4): 767-775.
Sivolella, S., F. Lumachi, et al. (2013). "Denosumab and anti-angiogenic drug-related osteonecrosis of the jaw: an uncommon but potentially severe disease." Anticancer Res 33 (5): 1793-1797.
Smith, M.R., F. Saad, et al. (2013). "Denosumab and bone metastasis-free survival in men with nonmetastatic castration-resistant prostate cancer: exploratory analyzes by baseline prostate-specific antigen doubling time." J Clin Oncol 31 (30): 3800-3806.
Sonis, S.T., L.S. Elting, et al. (2004). "Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients." Cancer 100 (9 Suppl): 1995-2025.
Soundia, A., D. Hadaya, et al. (2018). "Radiographic predictors of bone exposure in patients 0 medications osteonecrosis of the jaws." Oral Surg Oral Med Oral Pathol Oral Radiol.
Stopeck, A.T., K. Fizazi, et al. (2016). "Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer." Support Care Cancer 24 (1): 447-455.
Thumbigere-Math, V., B.S. Michalowicz, et al. (2014). "Periodontal disease as a risk factor for bisphosphonate-related osteonecrosis of the jaw." Journal of Periodontology 85 (2): 226-233.
Troeltzsch, M., D. Cagna, et al. (2016). "Is there an association to peri-implantitis?" Journal of cranio-maxillo-facial surgery: official publication of the European Association for Cranio-maxillo-Facial Surgery 44 (12): 1945-1951.
Voss, P.J., G. Vargas Soto, et al. (2016). "Sinusitis and oroantral fistula in patients with bisphosphonate-associated necrosis of the maxilla." Head Face Med 12: 3.
Wagner-Johnston, N.D., J.A. Sloan, et al. (2015). "5-year follow-up of a randomized controlled trial of immediate versus delayed zoledronic acid for the prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen: N03CC (Alliance) trial." Cancer 121 (15): 2537-2543.
Walter, C., B. Al-Nawas, et al. (2010). "Prevalence of bisphosphonate associated osteonecrosis of the jaws in multiple myeloma patients." Head Face Med 6 (1): 11.
Walter, C., B. Al-Nawas, et al. (2016). "Dental implants in patients treated with antiresorptive medication – a systematic literature review." Int J Implant Dent 2 (1): 9.
Wazzan, T., D. Kashtwari, et al. (2018). "Radiographic bone loss and the risk of medication-related osteonecrosis of the jaw (MRONJ) in multiple myeloma patients-A retrospective case control study." Special care in dentistry: official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry.
Yoneda, T., H. Hagino, et al. (2017). "Antiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw." J Bone Miner Metab 35 (1): 6-19.
Oral carcinoma As differing views on the type and extent of diagnosis, treatment and follow-up of oral carcinoma have existed so far, it was imperative…
A glance into the future of digital prosthetics Digital technologies offer a wide range of new opportunities in prosthetic treatment. The World Dental…
Observing with competence Do not just watch, but help yourself. As the everyday life of a practicing dentist feels, Dresden dentistry students can now…
Preserving the tried and tested – creating something new Dental heritage Dentistry is characterized by constant innovation – but it does not seem to look…